Stock listing
Dusseldorf:7PO Poxel SA Aktie
German listing (Dusseldorf) of Poxel SA · home listing Euronext:POXEL
Follow Poxel SA into a list and get an email when it puts out news.
Home listing price · EURONEXT:POXEL
€0.126 EUR -0.017 (-11.9%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:POXEL
- Day range
- €0.126 – €0.140 EURNov 20, 2026
- Volume
- 1.24M sharesNov 20, 2026
- Market cap
- €8.45M EURAt the close on Nov 20, 2026 · price × 66.96M shares outstanding
- 52-week range
- €0.126 – €0.480 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €122,440 EURMedian day 342,301 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:POXEL · Home | €0.126 EUR | -0.017 (-11.9%) | 1,242,193 | €0.140 | €0.140 | €0.126 | €0.143 | Close on Nov 20, 2026 |
| Frankfurt:7PO | €0.131 EUR | -0.006 (-4.4%) | — | €0.131 | €0.131 | €0.131 | €0.137 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:POXEL · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.126 | -0.017 | -11.9% | €0.140 | €0.140 | €0.126 | 1,242,193 | |
| €0.143 | -0.002 | -1.6% | €0.150 | €0.150 | €0.143 | 201,252 | |
| €0.146 | -0.003 | -2.0% | €0.149 | €0.149 | €0.144 | 178,824 | |
| €0.149 | +0.003 | +1.9% | €0.146 | €0.153 | €0.146 | 836,701 | |
| €0.146 | -0.004 | -2.8% | €0.154 | €0.154 | €0.145 | 414,963 | |
| €0.150 | -0.003 | -2.0% | €0.153 | €0.154 | €0.150 | 229,277 | |
| €0.153 | 0.000 | 0.0% | €0.153 | €0.156 | €0.153 | 210,539 | |
| €0.153 | -0.003 | -2.0% | €0.156 | €0.156 | €0.150 | 190,707 | |
| €0.156 | +0.004 | +2.8% | €0.152 | €0.157 | €0.152 | 273,768 | |
| €0.152 | -0.004 | -2.6% | €0.156 | €0.156 | €0.148 | 726,195 | |
| €0.156 | -0.002 | -1.3% | €0.159 | €0.160 | €0.156 | 176,856 | |
| €0.158 | +0.004 | +2.6% | €0.154 | €0.161 | €0.152 | 308,863 | |
| €0.154 | -0.006 | -3.8% | €0.160 | €0.163 | €0.152 | 438,787 | |
| €0.160 | -0.005 | -3.1% | €0.166 | €0.174 | €0.158 | 868,119 | |
| €0.165 | -0.006 | -3.6% | €0.172 | €0.172 | €0.163 | 345,436 | |
| €0.171 | +0.010 | +6.5% | €0.161 | €0.178 | €0.158 | 849,849 | |
| €0.161 | -0.002 | -1.0% | €0.163 | €0.163 | €0.158 | 565,070 | |
| €0.163 | -0.004 | -2.4% | €0.167 | €0.169 | €0.160 | 436,853 | |
| €0.167 | -0.007 | -3.9% | €0.173 | €0.173 | €0.162 | 498,929 | |
| €0.173 | -0.013 | -7.0% | €0.186 | €0.186 | €0.173 | 544,304 | |
| €0.186 | -0.011 | -5.4% | €0.197 | €0.197 | €0.184 | 419,071 | |
| €0.197 | +0.014 | +7.4% | €0.191 | €0.209 | €0.183 | 1,727,432 | |
| €0.183 | -0.040 | -17.8% | €0.223 | €0.243 | €0.180 | 3,848,782 | |
| €0.223 | +0.075 | +50.7% | €0.151 | €0.270 | €0.151 | 7,667,004 | |
| €0.148 | -0.008 | -5.1% | €0.156 | €0.156 | €0.147 | 855,115 | |
| €0.156 | -0.015 | -9.0% | €0.171 | €0.171 | €0.154 | 331,947 | |
| €0.171 | +0.021 | +13.8% | €0.151 | €0.184 | €0.151 | 1,645,713 | |
| €0.151 | +0.016 | +11.6% | €0.135 | €0.185 | €0.135 | 2,646,280 | |
| €0.135 | +0.001 | +0.7% | €0.135 | €0.136 | €0.134 | 341,110 | |
| €0.134 | +0.000 | +0.1% | €0.134 | €0.136 | €0.133 | 343,492 | |
| €0.134 | -0.001 | -0.7% | €0.135 | €0.136 | €0.134 | 141,807 | |
| €0.135 | +0.000 | +0.3% | €0.134 | €0.135 | €0.133 | 176,790 | |
| €0.134 | -0.003 | -2.2% | €0.135 | €0.137 | €0.132 | 466,679 | |
| €0.137 | -0.013 | -8.4% | €0.150 | €0.150 | €0.130 | 986,393 | |
| €0.150 | -0.016 | -9.9% | €0.167 | €0.167 | €0.150 | 786,453 | |
| €0.166 | -0.004 | -2.1% | €0.170 | €0.170 | €0.166 | 105,194 | |
| €0.170 | 0.000 | -0.1% | €0.170 | €0.170 | €0.167 | 98,523 | |
| €0.170 | -0.005 | -2.7% | €0.175 | €0.175 | €0.170 | 216,202 | |
| €0.175 | -0.001 | -0.8% | €0.177 | €0.177 | €0.175 | 139,529 | |
| €0.176 | +0.002 | +1.4% | €0.174 | €0.178 | €0.173 | 211,959 | |
| €0.174 | -0.004 | -2.2% | €0.178 | €0.180 | €0.174 | 269,633 | |
| €0.178 | -0.018 | -9.0% | €0.195 | €0.196 | €0.178 | 582,321 | |
| €0.196 | +0.014 | +7.8% | €0.182 | €0.208 | €0.181 | 1,818,659 | |
| €0.181 | +0.018 | +11.3% | €0.163 | €0.194 | €0.163 | 920,369 | |
| €0.163 | +0.001 | +0.9% | €0.162 | €0.163 | €0.161 | 136,146 | |
| €0.162 | -0.006 | -3.8% | €0.167 | €0.168 | €0.158 | 361,596 | |
| €0.168 | -0.010 | -5.6% | €0.178 | €0.178 | €0.166 | 336,659 | |
| €0.178 | +0.000 | +0.1% | €0.178 | €0.178 | €0.176 | 93,706 | |
| €0.178 | -0.003 | -1.4% | €0.180 | €0.180 | €0.176 | 260,035 | |
| €0.180 | -0.005 | -2.5% | €0.185 | €0.185 | €0.180 | 195,779 | |
| €0.185 | +0.001 | +0.8% | €0.184 | €0.186 | €0.184 | 201,202 | |
| €0.184 | -0.004 | -1.9% | €0.187 | €0.188 | €0.183 | 175,114 | |
| €0.187 | -0.005 | -2.4% | €0.190 | €0.192 | €0.186 | 240,624 | |
| €0.192 | -0.001 | -0.4% | €0.193 | €0.193 | €0.190 | 113,727 | |
| €0.193 | -0.004 | -2.1% | €0.197 | €0.197 | €0.182 | 372,280 | |
| €0.197 | 0.000 | -0.1% | €0.199 | €0.199 | €0.195 | 204,501 | |
| €0.197 | -0.001 | -0.4% | €0.200 | €0.200 | €0.195 | 425,154 | |
| €0.198 | -0.003 | -1.6% | €0.202 | €0.202 | €0.197 | 188,538 | |
| €0.201 | 0.000 | 0.0% | €0.195 | €0.203 | €0.195 | 442,611 | |
| €0.201 | -0.001 | -0.2% | €0.202 | €0.204 | €0.200 | 265,811 | |
| €0.202 | -0.005 | -2.7% | €0.205 | €0.210 | €0.202 | 214,820 | |
| €0.207 | -0.007 | -3.3% | €0.211 | €0.211 | €0.203 | 439,543 | |
| €0.214 | -0.022 | -9.3% | €0.237 | €0.250 | €0.213 | 1,529,547 | |
| €0.236 | +0.041 | +20.9% | €0.195 | €0.237 | €0.195 | 1,769,063 | |
| €0.195 | -0.001 | -0.5% | €0.196 | €0.196 | €0.195 | 68,360 | |
| €0.196 | -0.003 | -1.3% | €0.200 | €0.200 | €0.196 | 106,641 |
- Ticker
- Dusseldorf:7PO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Nov 9, 2026
Poxel nombre d’actions et de droits de vote composant le capital social
Latest news
Poxel nombre d’actions et de droits de vote composant le capital social
Nov 9, 2026
Closed €0.156 (+2.8%) on Nov 9, 2026
Poxel Reports Revenue for the Third Quarter of 2026
Oct 19, 2026
Closed €0.223 (+50.7%) on Oct 19, 2026
Mise à disposition de la Lettre aux Actionnaires de Poxel
Oct 12, 2026
Closed €0.135 (+0.7%) on Oct 12, 2026
Laure-Hélène Mercier Co-Opted as Chair of the Board of Directors of Poxel
Sep 3, 2026
Closed €0.193 (-2.1%) on Sep 4, 2026
Poxel Publishes Its Turnover for the Second Quarter of 2026 and Announces the Postponement of the Publication of Its 2025 Financial Statements
Jul 30, 2026
Closed €0.21 (+4.0%) on Jul 31, 2026
Poxel Appoints Yves Decadt as Chief Executive Officer to Accelerate Portfolio Development and Strategic Partnerships
Jun 10, 2026
Closed €0.214 (-4.0%) on Jun 11, 2026
Poxel Reports First Quarter 2026 Revenue and Provides a Business Update
May 20, 2026
Closed €0.255 (+2.6%) on May 20, 2026
Poxel: Postponement of the Publication of the 2025 Annual Financial Statements and the Annual Financial Report
Apr 30, 2026
Closed €0.251 (-2.3%) on May 4, 2026
Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million
Mar 31, 2026
Closed €0.387 (+68.3%) on Mar 31, 2026
Poxel Confirms the Drawdown Under the Additional Tranche D PDR Bond Issue as Part of the Continuation Plan
Mar 25, 2026
Closed €0.246 (+2.9%) on Mar 26, 2026
Poxel SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 34 in all · newest Nov 9, 2026 · oldest 2025
- Decks
- 13 decks · latest Oct 16, 2025
Where Poxel SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:POXEL · Home listing | Euronext | France | EUR |
| LSIN:0RA2 | LSIN | United Kingdom | EUR |
| Lang & Schwarz:A14M04 | Lang & Schwarz | Germany | EUR |
| LS Exchange:A14M04 | LS Exchange | Germany | EUR |
| Frankfurt:7PO | Frankfurt | Germany | EUR |
| OTC:PXXLF | OTC | United States | USD |
| Aquis:POXELP | Aquis | United Kingdom | EUR |
| Aquis:POXELP | Aquis | United Kingdom | EUR |
| Dusseldorf:7PO · This page | Dusseldorf | Germany | EUR |
| gettex:7PO | gettex | Germany | EUR |
| Hamburg:7PO | Hamburg | Germany | EUR |
| Munich:7PO | Munich | Germany | EUR |
| Stuttgart:7PO | Stuttgart | Germany | EUR |
| Turquoise:POXELP | Turquoise | United Kingdom | EUR |
Valuation
balance Jun 30, 2025 · price Nov 20, 2026
- Enterprise value
- €67.38M EUR
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Poxel SA · EURONEXT:POXEL | US$9.27M | US$73.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purple Biotech Ltd. · TASE:PPBT | US$9.70M | US$3.73M | n/a | n/a | n/a | 0.8× | n/a | 0.0× | n/a |
| Jasper Therapeutics, Inc. · NASDAQ:JSPR | US$9.64M | −US$125.6M | n/a | −15.7× | n/a | n/a | n/a | n/a | 2.02 |
| Alzinova AB · OMXSTO:ALZ | US$9.58M | US$8.35M | n/a | 17.0× | n/a | 0.6× | −484.4% | 0.0× | n/a |
| Chemomab Therapeutics Ltd. · NASDAQ:CMMB | US$9.58M | US$4.92M | n/a | n/a | n/a | 2.6× | n/a | 0.0× | 1.04 |
| Genvor Incorporated · OTC:GNVR | US$9.47M | US$9.27M | n/a | n/a | n/a | n/a | n/a | n/a | 0.44 |
| TScan Therapeutics, Inc. · NASDAQ:TCRX | US$9.27M | −US$30.80M | n/a | −5.9× | n/a | 0.2× | n/a | 0.9× | 1.66 |
| Rapid Dose Therapeutics Corp · CSE:DOSE | US$9.13M | US$9.12M | n/a | 5.1× | n/a | n/a | −123.1% | n/a | 0.64 |
| CytoMed Therapeutics Limited · NASDAQ:GDTC | US$9.01M | US$8.23M | n/a | 14.7× | n/a | 2.3× | −730.3% | 0.1× | 0.16 |
| PreveCeutical Medical Inc · CSE:PREV | US$8.97M | US$8.95M | n/a | n/a | n/a | n/a | n/a | n/a | 0.73 |
| BioLineRX Ltd. · TASE:BLRX | US$8.90M | US$10.13M | n/a | 8.6× | n/a | 0.5× | −171.7% | 0.3× | n/a |
| Median of the others | US$9.37M | US$8.29M | 6.8× | 0.7× | −328.0% | 0.1× | 0.73 |
Team and board
Officers
| Officer | Role |
|---|---|
| Yves Decadt | Chief Executive Officer |
| Antoine de Boissieu | Chief Financial Officer |
| Alexandre Massias | Investor Relations / Media |
| Aurélie Manavarere | Investor Relations / Media |
| Paul Boivin | Investor relations / Media |
| Théo Martin | Investor relations / Media |
| Thomas Cozzolino | Investor relations / Media |
Board
| Director | Role |
|---|---|
| Laure-Hélène Mercier | Chair of the Board of Directors |
| Amit Kohli | Independent Director |
| Yves Decadt | Chief Executive Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Dec 31, 2025 | Mar 25, 2026 | +2.7% |
| Quarter to Sep 30, 2025 | Nov 7, 2025 | +10.5% |
| Q2 2025 | Sep 23, 2025 | +1.3% |
| Quarter to Mar 31, 2025 | Apr 22, 2025 | +14.0% |
| Quarter to Sep 30, 2024 | Oct 3, 2024 | +12.3% |
| Quarter to Mar 31, 2024 | May 16, 2024 | −4.9% |
| Q4 2023 | Feb 15, 2024 · After close | −0.4% |
| Quarter to Sep 30, 2023 | Nov 8, 2023 · After close | −0.3% |
| Q2 2023 | Aug 30, 2023 · After close | −4.8% |
| Q1 2023 | May 3, 2023 · After close | −0.3% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2022 | Mar 23, 2023 · Before open | −3.3% |
| Q3 2022 | Oct 4, 2022 · After close | −5.8% |
| Q2 2022 | Aug 8, 2022 · After close | +13.0% |
| Q1 2022 | May 17, 2022 · After close | +2.9% |
| Q4 2021 | Mar 23, 2022 | −19.1% |
| Q3 2021 | Oct 20, 2021 · After close | −0.7% |
| Q2 2021 | Jul 21, 2021 · After close | +1.3% |
| Q1 2021 | Apr 21, 2021 · After close | 0.0% |
| Q4 2020 | Mar 24, 2021 · After close | −0.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2024 Earnings Presentation | Earnings | 17 slides | Oct 16, 2025 |
| Investor Presentation (December 2024) | Investor deck | 36 slides | December 2024 |
| FY2023 Earnings Presentation | Earnings | 27 slides | Oct 3, 2024 |
| H1 2023 Earnings Presentation | Earnings | 33 slides | Sep 26, 2023 |
| FY2022 Earnings Presentation | Earnings | 38 slides | Mar 23, 2023 |
| H1 2022 Earnings Presentation | Earnings | 43 slides | Sep 21, 2022 |
| FY2021 Earnings Presentation | Earnings | 27 slides | Mar 22, 2022 |
| H1 2021 Earnings Presentation | Earnings | 30 slides | Sep 23, 2021 |
| Investor Presentation (July 2021) | Investor deck | 33 slides | Jul 12, 2021 |
| FY2020 Earnings Presentation | Earnings | 42 slides | Mar 25, 2021 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (October 2020) | Technical | 19 slides | Oct 1, 2020 |
| H1 2020 Earnings Presentation | Earnings | 28 slides | Sep 15, 2020 |
| Technical Presentation (September 2016) | Technical | 13 slides | Sep 14, 2016 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Rights offering of new shares (capital increase with preemptive subscription rights) Update: rights offering Buyers: IPF (guarantees the capital increase, subject to not exceeding 29.9% of the Company's share capital following the transaction); IPF Invest Co 2 S.à.r.l. (guarantees the capital increase with preemptive subscription rights) | Apr 30, 2026 | |
| At-the-market programme of warrants to subscribe new ordinary shares (SmartATM equity line) Update: at-the-market programme Buyers: IRIS (Subscribed 40 million warrants; financing commitment of up to €5 million over five years in twenty €250,000 quarterly tranches) Insiders: The equity line does not create any conflict of interest for directors or corporate officers Use of proceeds: Secure the financial foundation needed to implement the company's recovery plan; part of the restructuring of IRIS bond debt | Feb 3, 2026 | |
| Bonds (IPF bond loan) Tranche closed: €500,000 raised Buyers: IPF Partners (bond issue for a maximum amount of €2.5 million under an additional Tranche D of the IPF bond loan); IPF (new bond borrowings of €3.75 million, in addition to €2.5 million of bonds issued during the observation period) Use of proceeds: Fund Poxel's financing needs under the recovery plan until it generates positive cash flow | Jan 30, 2026 | US$586,560 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in EUR
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.64M | 1.98M | 674.0K | 13.4M | 6.81M | 26.6M | 74.6M | 5.29M | 70.3K | 59.6K |
| Cost of revenue | 2.94M | 1.98M | 672.0K | 59.0K | 0 | 0 | 0 | 0 | 25.2K | |
| Gross profit | 3.69M | 1.00K | 2.00K | 13.3M | 6.81M | 26.6M | 74.6M | 5.29M | 70.3K | 34.5K |
| Research and development | 1.00M | 21.0M | 13.9M | 27.5M | 29.2M | 44.5M | 58.1M | 24.1M | 20.9M | 9.24M |
| Selling, general and administrative | 5.03M | 4.44M | 10.6M | 9.94M | 7.41M | 4.49M | 3.45M | 3.83M | 2.68M | |
| Operating income | -3.50M | -28.8M | -21.9M | -22.5M | -29.8M | -24.7M | 12.5M | -21.9M | -24.3M | -11.7M |
| Depreciation and amortization | 17.2M | 555.0K | 556.0K | 551.0K | 424.0K | 62.0K | 37.9K | 32.0K | 23.0K | |
| EBITDA | -11.6M | -21.3M | -21.9M | -29.3M | -24.2M | 12.6M | -21.9M | -24.3M | -11.7M | |
| Interest expense | 14.0M | 6.15M | 9.91M | 2.95M | 1.73M | 233.0K | 28.0K | 46.5K | 572.4K | 918.8K |
| Income before tax | -18.3M | -35.1M | -31.4M | -23.8M | -31.8M | -25.7M | 13.6M | -22.3M | -24.5M | -12.2M |
| Income tax | 2.00K | 2.00K | 2.00K | 2.00K | 36.0K | 1.00K | 77.0K | 395.9K | 200.6K | -124.2K |
| Net income | -18.3M | -35.1M | -31.4M | -23.8M | -31.8M | -25.7M | 13.5M | -22.7M | -24.5M | -12.2M |
| Earnings per share, basic | -0.38 | -1.05 | -1.08 | -0.83 | -1.16 | -0.99 | 0.54 | -0.99 | -1.16 | -0.68 |
| Earnings per share, diluted | -0.38 | -1.05 | -1.08 | -0.83 | -1.16 |
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.66M | 2.34M | 13.1M | 32.3M | 40.2M | 37.2M | 66.7M | 54.2M | 45.6M | 42.4M |
| Short-term investments | -86.0K | -193.0K | 3.53M | 24.6M | 19.0M | 59.4M | 50.0M | -184.3K | ||
| Receivables | 4.62M | 385.0K | 394.0K | 50.0K | 281.0K | 14.8M | 15.6M | 11.5M | 3.88M | 2.54M |
| Inventory | -1.56M | 0 | 1 | 898.0K | 1 | 552.3K | 617 | 226 | ||
| Current assets | 14.9M | 4.52M | 16.6M | 36.3M | 46.0M | 52.9M | 88.3M | 66.3M | 49.6M | 46.2M |
| Property, plant and equipment | 121.0K | 1.32M | 1.72M | 2.22M | 2.32M | 296.0K | 143.0K | 145.4K | 152.7K | |
| Total assets | 14.9M | 4.82M | 34.7M | 54.9M | 65.1M | 72.3M | 105.5M | 66.8M | 50.3M | 46.8M |
| Accounts payable | 2.05M | 3.30M | 4.41M | 8.42M | 8.36M | 10.2M | 8.65M | 3.25M | 4.92M | 2.82M |
| Current liabilities | 19.0M | 13.3M | 27.4M | 15.9M | 16.5M | 30.8M | 49.1M | 46.6M | 10.1M | 7.14M |
| Long-term debt | 40.1M | 24.5M | 29.0M | 19.5M | 62.0K | 359.0K | 555.0K | 708.6K | 1.55M | |
| Total debt | 47.0M | 43.4M | 35.1M | 23.6M | 7.70M | 14.2M | 1.31M | 1.58M | 3.15M | |
| Total liabilities | 53.9M | 53.0M | 46.7M | 38.2M | 33.2M | 49.7M | 47.4M | 10.9M | 8.82M | |
| Shareholders' equity | -58.9M | -49.1M | -18.2M | 8.21M | 27.1M | 39.1M | 55.8M | 19.3M | 39.4M | 38.0M |
| Shares outstanding | 38.6M | 29.1M | 28.6M | 27.5M | 25.9M | 24.8M | 23.0M | 21.1M | 17.9M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -9.51M | -14.0M | -21.8M | -16.9M | -25.7M | -25.7M | -4.74M | 8.13M | -18.8M | -10.1M |
| Capital spending | -17.0M | -11.0K | -28.0K | -235.0K | -113.0K | -7.88M | -35.8K | -24.6K | -143.9K | |
| Free cash flow | 3.05M | -21.8M | -16.9M | -26.0M | -25.8M | -12.6M | 8.09M | -18.9M | -10.2M | |
| Cash from investing | 92.0K | 41.0K | 0 | -42.0K | 52.0K | 352.0K | -7.61M | 213.1K | 179.8K | 96.9K |
| Cash from financing | 10.7M | 3.23M | 2.58M | 9.03M | 28.7M | -4.21M | 25.7M | -496.0K | 21.8M | 42.1M |
| Dividends paid | -250.0K | |||||||||
| Share buybacks | 0 | 295.0K | 16.9M | 1.03M | 12.2M | 546.0K | 26.8M | -250.0K | ||
| Change in cash | 1.31M | -10.7M | -19.2M | -7.92M | 3.02M | -29.6M | 13.3M | 7.84M | 3.16M | 32.2M |
Cap table
Built by 6ix from Poxel SA’s releases · as of Sep 29, 2025
- Common shares
- 66,959,377
- Fully diluted
- 66,959,377
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 66,959,377 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 66,959,377 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alexandre Massias | Investor Relations / Media · Since at least Sep 3, 2026 |
| Amit Kohli | Independent Director · Since at least Aug 1, 2025 |
| Antoine de Boissieu | Chief Financial Officer · Since at least Nov 5, 2026 |
| Arthur Rouillé | Investor relations / Media · Dec 10, 2025 – Nov 5, 2026 · Past |
| Aurélie Manavarere | Investor Relations / Media · Since at least Nov 20, 2025 |
| Laure-Hélène Mercier | Chair of the Board of Directors · Since at least Sep 3, 2026 |
| Paul Boivin | Investor relations / Media · Since at least Feb 16, 2026 |
| Théo Martin | Investor relations / Media · Since at least Jun 10, 2026 |
| Thomas Cozzolino | Investor relations / Media · Since at least Apr 30, 2026 |
| Yves Decadt | Chief Executive Officer · Since Jun 10, 2026 |
Log in to ask 6ix AI your own questions about Poxel SA.